Confervo Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-05-2024
- Paid Up Capital ₹ 0.88 M
as on 27-05-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2022)
- Ebitda
- Net Worth
- Total Assets %
(FY 2022)
About Confervo Formulations
The Company is engaged in the Jewelry & Fashion Accessories Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.88 M, as per Ministry of Corporate Affairs (MCA) records.
Jayaraman Thirumal, Marimuthu Krishnan, Mohan Babu, and One other member serve as directors at the Company.
- CIN/LLPIN
U33309TN2018PTC122670
- Company No.
122670
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Confervo Formulations?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayaraman Thirumal  | Director | 14-May-2018 | Current |
| Marimuthu Krishnan | Director | 14-May-2018 | Current |
| Mohan Babu | Director | 14-May-2018 | Current |
| Senthilkumar Murugesan | Director | 14-May-2018 | Current |
Financial Performance of Confervo Formulations.
Confervo Formulations Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Confervo Formulations?
Unlock access to Confervo Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Behandler Pharmaceuticals Private LimitedActive 1 year 5 monthsSenthilkumar Murugesan is a mutual person
- Pharmacien Life Sciences Private LimitedActive 10 years 5 months
Senthilkumar Murugesan is a mutual person
- Victomed Pharmaceuticals Private LimitedActive 7 years 5 months
Senthilkumar Murugesan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Confervo Formulations?
Unlock and access historical data on people associated with Confervo Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Confervo Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Confervo Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
